The V617F JAK2 mutation is uncommon in cancers and in myeloid malignancies other than the classic myeloproliferative disorders

Blood. 2005 Oct 15;106(8):2920-1. doi: 10.1182/blood-2005-05-2087.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cells, Cultured
  • Genetic Testing
  • Humans
  • Janus Kinase 2
  • Multiple Myeloma / enzymology*
  • Multiple Myeloma / genetics*
  • Mutation / genetics*
  • Myeloproliferative Disorders / enzymology*
  • Myeloproliferative Disorders / genetics*
  • Protein-Tyrosine Kinases / genetics*
  • Proto-Oncogene Proteins / genetics*
  • Valine / genetics*

Substances

  • Proto-Oncogene Proteins
  • Protein-Tyrosine Kinases
  • JAK2 protein, human
  • Janus Kinase 2
  • Valine